Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy

Archives of Dermatological Research

Volumn 301, Issue 10, 2009, Pages 719-723

  Khalilzadeh, Omid ^a   Mojazi Amiri, Hoda ^a   Tahvildari, Maryam ^a   Anvari, Mehdi ^a   Esteghamati, Alireza ^b   Mobarra, Zahra ^c   Tehranchinia, Zohreh ^d   Rashidi, Armin ^b   Amirzargar, Aliakbar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CTLA 4 gene; Graves' dermopathy; Graves' disease; Polymorphism; Pretibial myxedema

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXON; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; OUTPATIENT DEPARTMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; LEG DERMATOSES; MALE; MYXEDEMA; POLYMORPHISM, SINGLE NUCLEOTIDE; TIBIA;

EID: 70349613459     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0919-1     Document Type: Article

References (32)

1. SS Amundsen AT Naluai H Ascher, et al. 2004 Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease Tissue Antigens 64 593 599 10.1111/j.1399-0039.2004.00312.x 15496203 10.1111/j.1399-0039.2004.00312.x 1:CAS:528:DC%2BD2cXhtVKjsrbL (Pubitemid 39472925)
2. RS Bahn 2003 Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease J Clin Endocrinol Metab 88 1939 1946 10.1210/jc.2002-030010 12727937 10.1210/jc.2002-030010 1:CAS:528: DC%2BD3sXjs1Oktro%3D (Pubitemid 36549860)
3. Y Ban T Tozaki M Taniyama M Tomita Y Ban 2005 Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population Autoimmunity 38 151 153 10.1080/08916930500050319 16040335 10.1080/08916930500050319 1:CAS:528:DC%2BD2MXkslSrt7c%3D (Pubitemid 40872739)
4. T Bednarczuk B Gopinath R Ploski JR Wall 2007 Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67 3 19 10.1111/j.1365-2265.2007.02854.x 10.1111/j.1365-2265.2007.02854.x 1:CAS:528:DC%2BD2sXovFKitrw%3D (Pubitemid 46955456)
5. Burns DA, Breathnach SM, Cox N, Griffiths CE (2004) Rook's textbook of dermatology. Blackwell Science, Oxford
6. HS Cheung JT Nicoloff MB Kamiel L Spolter ME Nimni 1978 Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema J Invest Dermatol 71 12 17 10.1111/1523-1747.ep12543646 355562 10.1111/1523-1747.ep12543646 1:CAS:528:DyaE1cXksFOrsLc%3D
7. DA Chistiakov KV Savost'anov RI Turakulov IA Efremov LM Demurov 2006 Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease Clin Immunol 118 233 242 10.1016/j.clim.2005.09.017 16297665 10.1016/j.clim.2005.09. 017 1:CAS:528:DC%2BD28Xhtlars7g%3D (Pubitemid 43204318)
8. V Fatourechi M Pajouhi AF Fransway 1994 Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases Medicine (Baltimore) 73 1 7 10.1097/00005792-199401000-00001 1:STN:280:DyaK2c7kt1Gisg%3D%3D
9. V Fatourechi GB Bartley GZ Eghbali-Fatourechi CC Powell DD Ahmed JA Garrity 2003 Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy Thyroid 13 1141 1144 10.1089/10507250360731541 14751035 10.1089/10507250360731541
10. V Fatourechi 2005 Pretibial myxedema: pathophysiology and treatment options Am J Clin Dermatol 6 295 309 10.2165/00128071-200506050-00003 16252929 10.2165/00128071-200506050-00003 (Pubitemid 41577404)
11. J Furszyfer LT Kurland WM McConahey LR Elveback 1970 Graves' disease in Olmsted County, Minnesota, 1935 through 1967 Mayo Clin Proc 45 636 644 5469087 1:STN:280:DyaE3c3psVaqtg%3D%3D
12. SC Gough LS Walker DM Sansom 2005 CTLA4 gene polymorphism and autoimmunity Immunol Rev 204 102 115 10.1111/j.0105-2896.2005.00249.x 15790353 10.1111/j.0105-2896.2005.00249.x 1:CAS:528:DC%2BD2MXkslGns78%3D (Pubitemid 40460496)
13. H Hadj Kacem M Bellassoued N Bougacha-Elleuch M Abid H Ayadi 2001 CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease Clin Immunol 101 361 365 10.1006/clim.2001.5121 11726229 10.1006/clim.2001.5121 1:STN:280:DC%2BD3MnotVaqtA%3D%3D
14. HF Harbo EG Celius F Vartdal A Spurkland 1999 CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis Tissue Antigens 53 106 110 10.1034/j.1399-0039.1999.530112.x 10082437 10.1034/j.1399-0039.1999.530112.x 1:CAS:528:DyaK1MXhslSqtbw%3D (Pubitemid 29084180)
15. AE Heufelder BE Wenzel PC Scriba 1996 Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease J Clin Endocrinol Metab 81 3733 3739 10.1210/jc.81.10.3733 8855831 10.1210/jc.81.10.3733 1:CAS:528:DyaK28XmtlCmu78%3D (Pubitemid 26339947)
16. J Heward C Gordon A Allahabadia AH Barnett JA Franklyn SC Gough 1999 The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus Ann Rheum Dis 58 193 195 10364920 10.1136/ard.58.3.193 1:CAS:528:DyaK1MXmslOjs7g%3D
17. T Kalantari H Mostafavi AM Pezeshki, et al. 2003 Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease Autoimmunity 36 313 316 10.1080/0891693032000114544 14567561 10.1080/0891693032000114544 1:CAS:528:DC%2BD3sXmtVemtLc%3D (Pubitemid 36992452)
18. T Kouki Y Sawai CA Gardine ME Fisfalen ML Alegre LJ DeGroot 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease J Immunol 165 6606 6611 11086105 1:CAS:528:DC%2BD3cXosFOhtr4%3D
19. JP Kriss 1987 Pathogenesis and treatment of pretibial myxedema Endocrinol Metab Clin North Am 16 409 415 3319589 1:STN:280:DyaL1c%2Fot1Ojtg%3D%3D
20. A Ligers N Teleshova T Masterman WX Huang J Hillert 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2 145 152 10.1038/sj.gene.6363752 11426323 10.1038/sj.gene.6363752 1:CAS:528:DC%2BD3MXksVyisbc%3D (Pubitemid 33674879)
21. H Nakkash-Chmaisse RF Makki E Abdelhamid H Fakhoury NN Salti I Salti 2004 CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population Eur J Immunogenet 31 141 143 10.1111/j.1365-2370.2004.00455. x 15182328 10.1111/j.1365-2370.2004.00455.x 1:CAS:528:DC%2BD2cXmt1ynur0%3D (Pubitemid 38845119)
22. YJ Park HK Chung DJ Park, et al. 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans Thyroid 10 453 459 10907987 10.1089/thy.2000.10.211 1:STN:280:DC%2BD3M%2Fjs1Chsw%3D%3D
23. A Petrone G Giorgi A Galgani, et al. 2005 CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population Thyroid 15 232 238 10.1089/thy.2005.15.232 15785242 10.1089/thy.2005.15.232 1:CAS:528: DC%2BD2MXisFWis7o%3D (Pubitemid 40418690)
24. BS Prabhakar RS Bahn TJ Smith 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy Endocr Rev 24 802 835 10.1210/er.2002-0020 14671007 10.1210/er.2002-0020 1:CAS:528: DC%2BD2cXltVegsA%3D%3D (Pubitemid 38067700)
25. KM Schwartz V Fatourechi DD Ahmed GR Pond 2002 Dermopathy of Graves' disease (pretibial myxedema): long-term outcome J Clin Endocrinol Metab 87 438 446 10.1210/jc.87.2.438 11836263 10.1210/jc.87.2.438 1:CAS:528: DC%2BD38XhsVSjtL8%3D (Pubitemid 34158200)
26. B Vaidya H Imrie P Perros, et al. 1999 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy Lancet 354 743 744 10.1016/S0140-6736(99)01465-8 10475192 10.1016/S0140-6736(99)01465-8 1:STN:280:DyaK1Mvgt1WktQ%3D%3D (Pubitemid 29405794)
27. MP Vanderpump WM Tunbridge JM French, et al. 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey Clin Endocrinol (Oxf) 43 55 68 10.1111/j.1365-2265.1995.tb01894.x 10.1111/j.1365-2265.1995.tb01894.x 1:STN:280:DyaK2MzmvVyltA%3D%3D
28. TL Walunas DJ Lenschow CY Bakker, et al. 1994 CTLA-4 can function as a negative regulator of T cell activation Immunity 1 405 413 10.1016/1074-7613(94) 90071-X 7882171 10.1016/1074-7613(94)90071-X 1:CAS:528:DyaK2cXmt1yhurw%3D (Pubitemid 2134466)
29. AP Weetman 2000 Graves' disease N Engl J Med 343 1236 1248 10.1056/NEJM200010263431707 11071676 10.1056/NEJM200010263431707 1:STN:280:DC%2BD3M7ksVSjsQ%3D%3D (Pubitemid 30792752)
30. SC Werner 1977 Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association J Clin Endocrinol Metab 44 203 204 576230 10.1210/jcem-44-1-203 1:STN:280:DyaE2s%2FpsVWhsQ%3D%3D
31. Q Zhang YM Yang XY Lv 2006 Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene J Zhejiang Univ Sci B 7 887 891 10.1631/jzus.2006.B0887 17048303 10.1631/jzus.2006.B0887 1:CAS:528: DC%2BD2sXmtl2lsw%3D%3D
32. A Zhernakova P Eerligh P Barrera, et al. 2005 CTLA4 is differentially associated with autoimmune diseases in the Dutch population Hum Genet 118 58 66 10.1007/s00439-005-0006-z 16025348 10.1007/s00439-005-0006-z 1:CAS:528:DC%2BD28Xjs1Sntg%3D%3D